These results indicate that thromboplastic activity of tumour cells might be important in forming microthrombi in the lodgement phase and might be one of the factors facilitating blood-borne metastasis.
AMONG the factors influencing lodgement of tumour cells, their thromboplastic activity (Wood, 1958) , the size of tumour-cell clumps (Allen-Liotta et at., 1976) and deformability of tumour cells (Sato and Suzuki, 1976) have been listed.
Fibrinogen (Hagmar, 1972; Ivarsson, 1976; Tanaka et al., 1977) , platelets (Warren and Vales, 1972; Gasic et al., 1973) and damaged endothelium (Fidler and Zeidman, 1972; Withers and Milas, 1973) have been added as host factors for this event. It is still controversial, however, which factor is the most important in lodgement of tumour cells.
Mechanisms of extravasation of tumour cells also remain obscure. Three types of extravasation have been reported in the literature up to the present. First is the Marchesi-Florey type (Marchesi and Florey, 1961) of diapedesis of tumour cells proposed by Wood (1958) and Ludatscher et al. (1967) ; second is that proposed by Warren (1973) who showed tumour cells in emboli progressing through damaged vessel walls; and the third is described by Chew et al. (1976) who showed multiple breaching of endothelial cells with the processes of arrested tumour cells.
It has so far been stressed that tumour cells have both thromboplastic and fibrinolytic activities, and that these properties vary between cell line (Kodama et al., 1972) .
In the present study, using ascites hepatomas, the features of lodgement and extravasation of tumour cells with high and low thromboplastic activities are illustrated by electron microscopy, and the role of the thromboplastic activity of tumour cells in blood-borne metastasis is discussed.
MATERIALS AND METHODS
A closed colony strain of Donryu rats, weighing 100-150 g, supplied from the Institute for Animal Experiment of Kyushu University was used in the experiments.
Two lines of ascites hepatoma cells, AH 130 and AH 130 F(N), which were generously given by Sasaki Institute in Tokyo, Japan, and maintained in our laboratory by routine i.p. transplantation, were used.
AH 130 is an ascitic form of hepatoma cells induced by aminoazo dye (Aruji, 1953) and its high thromboplastic and high fibrinolytic activities were confirmed by Kodama et al. (1972) . AH 130 F(N) is a free-cell type (Hirono et al., 1964) , and was proved to have low thromboplastic and low fibrinolytic activities (Kodama et al., 1972) .
Tumour cells harvested 7-9 days after implantation were washed x 3 with physiological saline to eliminate blood components, suspended in physiological saline to adjust the number to 5 x 107/ml, and tested for viability with trypan-blue vital staining. Viability of the inoculated tumour cells was 90-99%. Each rat was injected with 0-2 ml of the tumour-cell suspension into the tail vein.
For electron-microscopic observations, 24 rats were inoculated with AH 130 and a further 24 with AH 130 F(N). All the rats were killed at various times from 1 min to 72 h after injection of the tumour cells. The lungs of the rats were cut into small pieces, fixed in 3% buffered glutaraldehyde, washed with 01M cacodylate buffer, postfixed with 1% buffered osmium tetroxide, dehydrated by graded ethanol, embedded in Epon 812, and cut on an LKB ultrotome. Many thick sections were examined by light microscopy to locate the tumour cells arrested in the pulmonary vessels. Appropriate areas in thick sections were then cut into thin sections, which were stained with uranyl acetate and lead acetate.
Forty-four rats were subjected to the experiment for observing microthrombi formed around the tumour-cell emboli. Of 23 rats injected i.v. with 107/0.2 ml of cell suspension of AH 130, 11 were killed immediately after the injection and 12 after 1 h. For AH 130 F(N), 21 rats were treated similarly. The lungs were fixed with 10% aqueous formaldehyde cut through the hilus of the lung, processed to paraffin sections 4 ,tm thick and stained with haematoxylin and eosin (H. & E.) . These sections were examined under the light microscope. Microthrombi on the whole area of the lung were counted.
Furthermore, to observe the effect of thromboplastic activity of tumour cells on blood-borne metastasis, 18 rats were divided into 2 groups. The first group of 10 rats was injected with 107 cells per 0-2 ml of AH 130, and 8 rats in the second group were injected with the same number of AH 130 F(N) cells. All the rats were killed after 72 h. The lungs were fixed in 10% aqueous formaldehyde, cut through the hilus of the lung, processed to paraffin sections and stained with H. & E. The sections through the hilus were examined under the light microscope. The metastatic foci in each section, 4 ,um thick, were counted over the whole area and expressed as the number per mm2.
RESULTS

Light-microscopic observations
Soon after i.v. injection of tumour cells, tumour-cell emboli, often associated with aggregation of platelets and/or deposition of fibrin, were seen in arterioles and capillaries of the lung. As shown in the Table, these microthrombi were more frequently found in the rats injected with AH 130 than those with AH 130 F(N). Within 1 h after the injection, thrombi containing the tumour cells became compact in the rats injected with AH 130, while they remained loose in the rats injected with AH 130 F(N). Later, the majority of the tumour cells disappeared from the pulmonary vessels. Forty-eight hours after the injection, the metastatic foci were formed mainly in alveolar septa and periarteriolar areas in the rats injected with AH 130, and in subpleural and perivenular areas in the rats injected with AH 130 F(N). Thrombi were sparse then in small arteries, arterioles and capillaries, in both experimental groups. The number of metastatic foci per mm2 of lung 3 days after i.v. injection of the tumour cells was as follows: 4-5 (±1-9) in the rats injected with AH 130 and 2-0 (± 1.2) in those injected with AH 130 F(N).
The difference was statistically significant (P<0 01).
Electron-microscopic observations
Electron microscopic findings at various times after injection of the tumour cells were as follows: Within 10 min.-In rats injected with AH 130, most of the tumour-cell emboli were found in the small arteries, arterioles and capillaries, and was closely associated with aggregation of platelets and deposition of a small amount of fibrin (Fig. 1) . Such tumour-cell emboli accounted for 89-6% of the 87 arrested emboli observed by electron microscopy. The majority of the small blood vessels with tumour-cell emboli were markedly dilated, and their endothelial cells were flattened. However, there was still no definite evidence of destruction or degeneration of endothelial cells (Fig. 1) . Some tumour cells were arrested within capillaries, irrespective of aggregation of platelets, or deposition of fibrin, and such emboli accounted for 10.4%.
Concerning AH 130 F(N), aggregation of platelets was less conspicuous and less frequent (Fig. 8) . Platelets around the tumour cells were loosely aggregated together. Tumour-cell emboli with loosely aggregated platelets accounted for 6 8% of the 50 arrested emboli. Most of the tumour cells were within capillaries with no aggregation of platelets or deposition of fibrin.
Fibrillar matrix was occasionally found between the tumour cells, both AH 130 and AH 130 F(N), arrested in the pulmonary vessels. In the periphery of this matrix, a basement-membrane-like structure was noted (Fig. 1) .
One to three hours.-In the rats injected with AH 130, the tumour-cell emboli became compact. Aggregated platelets showed formation of pseudopods and degranulation. Deposition of matured fibrin was also observed in the emboli. The endothelial cells were detached from the basement membrane or subendothelial layer (Fig. 2) . Some tumour cells were closely adherent to the basement membrane, where fragments of endothelial cells were occasionally found (Fig. 2) .
In places, the tumour cells closely adhered to and extended cytoplasmic processes to the endothelial cells forming indentation ( Fig. 3 and 4) . Occasionally, cytoplasmic processes of the tumour cells penetrated through the endothelial defects (Fig. 5) . Mitotic figures were sometimes noted (Fig. 2) .
In the rats injected with AH 130 F(N), a few platelets loosely aggregated around the tumour cells 1 h later. No remarkable changes were found in the endothelial cells, and intercellular junctions were intact by this time. A few tumour cells had escaped from capillaries 3 h after injection, but most of the tumour cells remained within arterioles and capillaries.
Six hours.-The tumour-cell emboli associated with the degenerated platelet mass were noted within arterioles and capillaries in the rats injected with AH 130. In these areas, fragments of the endothelial cells remained at intervals (Fig. 6) . basement membrane at the site of large endothelial defects (Fig. 6) . Endothelial cells containing a few pinocytic vesicles were irregularly detached from the basement membrane (Fig. 6) . In places, cell debris containing degenerated platelets flowed out into the interstitium through the endothelial defects where the basement membrane and the elastic membrane were also irregularly disrupted (Fig. 6) (Fig. 7) . In rats injected with AH 130 F(N), the tumour cells showed extravascular growth, forming cell nests in which capillaries were occasionally found. Warren and Vales (1972) proposed 2 types of adherent-tumour cell emboli, but 3 types were noted in the present study. The first type had dense aggregation of platelets and formation of fibrin, and was followed by severe structural changes of the endothelial cells. It is noteworthy that tumour-cell emboli with aggregation of platelets and deposition of fibrin were more prominently and more frequently found in rats injected with tumour cells with high thromboplastic activity. The second type had loosely aggregated platelets and the third had no aggregation of platelets or formation of fibrin. The latter 2 types were mainly observed when tumour cells with low thromboplastic activity were injected. Hilgard (1973) considered that embolic tumour cells led to endothelial damage, inducing local thrombin formation with subsequent irreversible platelet aggregation. Platelet-aggregating activity of certain tumour cells was also recognized by some authors (Gasic et al., 1973; Tanaka et al., 1977 ). The present study shows, however, no endothelial injury at the embolized sites soon after injection of tumour cells. This situation may lead to intimate participation of the tissue thromboplastin from tumour cells in aggregation of platelets and formation of fibrin, although damaged endothelial cells may participate later in adhesion and aggregation of platelets as described by Fisher et al. (1967) and Hilgard (1973) .
DISCUSSION
The present experiment, involving counting the number of the metastatic foci 3 days after the injection, appeared to indicate that formation of the first type of tumour-cell embolus was the most important event closely associated with the lodgement of the circulating tumour cells. Warren (1973) believed that only tumour-cell emboli with dense aggregation of platelets and formation of fibrin could develop into metastatic foci. The mechanisms by which tumour cells are extravasated are controversial. Wood (1958) conjectured that tumour cells penetrated the vessel walls damaged by a histamine-like substance released from damaged tumour cells, similar to the manner of diapedesis of neutrophils (Marchesi and Florey, 1961) . On the basis of electron-microscopic observations of pulmonary metastases by Ludatscher et al. (1967) it was concluded that within hours leucocytes accumulated and penetrated the endothelium through which tumour cells migrated. Sindelar et al. (1975) considered that fibrosarcoma cells could penetrate the endothelium at the intercellular junctions. Warren (1973) believed that adherent tumour-cell emboli with dense aggregates of platelets and deposition of fibrin were able to penetrate the vessel walls. Recently, Chew et al. (1976) proposed another type of extravasation, in which tumour cells arrested in the vessels destroyed the endothelial cells, breached the basement membrane by attrition, and finally invaded the surrounding tissue through defects of the basement membrane. Thus, 3 main hypotheses have been advanced to explain how circulating tumour cells escape from the blood vessels.
When the tumour cells with high thromboplastic activity were injected i.v., endothelial injury resulted mainly from tumour-cell emboli with dense aggregation of platelets and formation of fibrin, and appeared to be a characteristic feature of the extravasation of tumour cells. An extension of the cytoplasmic processes of tumour cells to the endothelial cells, and to the subendothelial space at the site, with desquamation of the endothelial cells, was occasionally found. However, it failed to reveal how tumour cells could penetrate the endothelium through the intercellular junctions. Accordingly, it was suggested that at least 2 forms of extravasation, proposed by Warren (1973) and Chew et at. (1976) respectively, could participate, especially with tumour cells of high thromboplastic activity. When tumour cells had a low thromboplastic activity, there were no severe structural changes of the endothelial cells in the whole process from lodgement to extravasation.
